April 15, 2024

Antibody Based Cell Surface Markers Identification is the largest segment driving the growth of the Cell Surface Markers Detection Market

Market Overview:

Cell surface markers detection helps in identifying different cell types in various research and diagnostic processes. It aids in identification of cell differentiation stage, activation state and other cell properties for diagnostic and research applications.

Market Key Trends:

Increasing applications of cell identification in cancer research and diagnostics is one of the major trends in the cell surface markers detection market. Cell surface marker analysis helps in understanding cancer progression and development of new targeted therapies. It is also utilized for monitoring cancer status and treatment response. Rising incidence of cancer across the globe is consequently propelling demand for cell surface markers detection products. According to WHO, cancer burden is expected to grow to 27.5 million new cases and 16.3 million cancer deaths by 2040. This rising cancer prevalence will continue driving the cell surface markers detection market during the forecast period.

Market key trends:
The cell surface markers detection market is witnessing increasing adoption of flow cytometry techniques for detection of cell surface markers. Flow cytometry allows detection of multiple cell surface markers simultaneously, providing comprehensive immune profiling. Advancements in flow cytometry such as development of high throughput systems and inclusion of lasers with new wavelengths are supporting improved detection of surface markers. Growing application of cell surface markers in disease diagnosis and monitoring is also driving the market. Identification of new cell surface markers through research will further expand application scope in areas such as cancer immunotherapy.

SWOT Analysis
Strengths: Flow cytometry technique enables detection of multiple markers at one time. Identification of new cell surface markers is expanding applications in disease diagnosis and treatment.
Weaknesses: High costs associated with flow cytometers limits adoption in low resource settings. Stringent regulatory requirements prolong approval times for new detection techniques and products.
Opportunities: Increasing research activity especially in immuno-oncology is revealing new potential cell surface marker targets. Emerging economies in Asia Pacific provide significant growth opportunities.
Threats: Presence of low-cost substitutes like ELISA limits pricing power of key players. Stringent privacy and data security laws may affect adoption of digital platforms for immune profiling.

Key Takeaways

The Global Cell Surface Markers Detection Market Demand  is expected to witness high growth, exhibiting CAGR of 9.1% over the forecast period, due to increasing research activity in disease diagnosis and immune-oncology. The market size for 2023 is estimated to be US$ 5,459.5 Mn.

Regional analysis: North America dominates the market currently due to presence of major players and availability of reimbursement. Asia Pacific is expected to grow at highest rate over the forecast period supported by increasing research funding and healthcare investments in countries like China and India.

Key players operating in the Cell Surface Markers Detection market include Grifols SA, Abbott Laboratories, Sysmex Corporation, Agilent Technologies Inc., Nexcelom Bioscience, Thermo Fisher Scientific Inc., Siemens Healthineers, Nihon Kohden Corporation, F. Hoffmann-La Roche Ltd., Bio Rad Laboratories Inc., Becton, Dickinson and Company (BD), Qiagen NV, Diasorin SpA (Luminex Corporation), Danaher Corporation (Beckman Coulter Inc.), and IVD Medical Holding Limited (Immucor Inc.), among others. These players are focusing on new product launches and expansion in emerging markets through collaborations.

Note:

  1. Source: Coherent Market Insights, Public sources, Desk research
  2. We have leveraged AI tools to mine information and compile it